|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
A Sweet Deal: How Amira Reinvented Itself as a Drug Discovery Engine
|
Bruce V. Bigelow |
12/23/11 |
San Diego
|
|
EnVivo, Biogen, Momenta, & Other Boston-Area Life Sciences Newsmakers
|
Erin Kutz |
12/09/11 |
Boston
|
|
Sanford-Burnham Joins Fold at Pfizer’s Centers for Therapeutic Innovation
|
Bruce V. Bigelow |
11/03/11 |
San Diego
|
|
GSK and Unilever Among Early Adopters of BioLeap’s Technology for Creating New Molecules
|
Arlene Weintraub |
08/23/11 |
New York
|
|
Organovo’s Bio-Printing Technology Yields Unanticipated Revenue from Pharma Partners
|
Bruce V. Bigelow |
07/13/11 |
San Diego
|
|
3D Biomatrix Hopes To Break Into Drug Discovery Market With 3D Testing Devices
|
Thomas Lee |
07/07/11 |
Detroit
|
|
Nimbus, Seeded by Bill Gates, Raises $24 Million For Computer-Aided Drug Discovery
|
Arlene Weintraub |
06/28/11 |
Boston
|
|
Constellation Pharma Raises $15M for Epigenetic Drugs
|
Gregory T. Huang |
06/06/11 |
Boston
|
|
Former Pfizer R&D Chief Urges Big Pharma To Go Small
|
Thomas Lee |
04/21/11 |
Detroit
|
|
From Human Tissue Supplier to R&D Contractor to BioBank Builder, Asterand Seeks Its Future
|
Thomas Lee |
03/16/11 |
Detroit
|
|
Entrega Emerges From Enlight
|
Gregory T. Huang |
01/10/11 |
Boston
|
|
Testing Experimental Drugs in Combination – A New Trend
|
Troy Wilson |
12/22/10 |
San Diego
|
|
Taking a VC Approach to Charity, Greylock Veteran’s Alzheimer’s Research Foundation “Dares to Be Great”
|
Erin Kutz |
08/25/10 |
Boston
|
|
Aileron Inks Deal with Roche, Worth Up to $1.1B, to Develop Stapled Peptide Drugs
|
Gregory T. Huang |
08/24/10 |
Boston
|
|
Nonprofits and the Valley of Death in Drug Discovery
|
Walter Moos |
08/19/10 |
San Francisco
|
|
Apredica Acquired by Cyprotex
|
Gregory T. Huang |
08/06/10 |
Boston
|
|
2010′s Innovative Dozen: The XSITE Xpo Showcase Companies
|
Erin Kutz |
06/14/10 |
Boston
|
|
The Genomics Comeback
|
Sylvia Pagán Westphal |
06/10/10 |
National
|
|
Using MIT-Harvard Technology, Ligon Discovery Speeds Up Search for New Drugs
|
Ryan McBride |
05/04/10 |
Boston
|
|
Gene Network Sciences Using Supercomputing to Match Patients with a Drug That Works
|
Ryan McBride |
04/27/10 |
Boston
|
|
Dyax in $12M Royalty Deal
|
Ryan McBride |
04/20/10 |
Boston
|
|
Halozyme Pursues Anti-Cellulite Drug, Optimer’s Antibiotic Kills C. Difficile Germs, Tragara Pharmaceuticals Raises Funds & More San Diego Life Sciences News
|
Denise Gellene |
02/11/10 |
San Diego
|
|
Seahorse Buys BioProcessors, Raises $6M
|
Wade Roush |
03/10/09 |
Boston
|
|
Burnham Gets $10M Donation
|
Bruce V. Bigelow |
01/30/09 |
San Diego
|
|
San Diego’s Forward Ventures Moves Toward a Lean and Virtual Future
|
Bruce V. Bigelow |
01/07/09 |
San Diego
|
|
Ardea Raises $30.6M in Stock Sale
|
Gregory T. Huang |
12/19/08 |
San Diego
|
|
Forma Buys SolMap Assets
|
Wade Roush |
10/02/08 |
Boston
|
|
Link Medicine Raises $40 Million to Counter Neurodegenerative Disease
|
Wade Roush |
09/30/08 |
Boston
|
|
Gov. Patrick Travels West to Plug Massachusetts’ Life Sciences Initiative At BIO
|
Luke Timmerman |
06/16/08 |
Boston
|
|
Let the Epic Curing Begin: Epix and Curis Earn Milestone Payments
|
Erik Mellgren |
05/05/08 |
Boston
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.